Khairy: No Medical Cannabis Products Registered Yet, MoH Welcomes Proposals For Clinical Trials

A cannabis plant with it’s oil extract. (Source: Open Access Government)

Health Minister Khairy Jamaluddin has said that his ministry welcomes proposals from anyone possessing knowledge or scientific proof of marijuana’s medical benefits.

He also clarified that there are currently no cannabis (or marijuana) related products currently approved for use in Malaysia.

This follows on from his earlier pledge that the government would allow the drug for medical use after passing strict conditions.

Khairy addressing Parliament yesterday, 17 November. (Source: Sinar Harian)

“The current laws which govern cannabis and its byproducts in Malaysia – the Dangerous Drugs Act 1952, Poisons Act 1952, and Sale of Drugs Act 1952 – does not forbid cannabis use for medical purposes,” he was quoted as saying by Astro Awani.

Khairy also said that anyone with sufficient scientific evidence of the drug’s quality, safety, and efficacy can apply to the Ministry of Health affiliated National Pharmaceuticals Regulatory Agency (NPRA) and Drug Control Authority (DCA) for a license.

“This allows the product to be reviewed and then registered under the Control of Drugs and Cosmetics Regulations 1984, which then allows it to be sold in the country.”

(source: GW Pharmaceuticals/Code Blue)

Khairy said that the ministry had registered only a single product previously – the CBD based mouth spray Sativex – back in 2014. The product is used to treat muscle spasms and spasticity linked to the incurable disease multiple sclerosis (MS).

However, Sativex was deregistered at its manufacturer GW Pharmaceuticals’ request in 2017, citing that the product was not commercially viable.